marginally significantp = 0.047
Nonmedicated patients showed a marginally significant increase in COX‐2 expression ( p = 0.047) and a significantly (−62%) reduced cPGES expression in frontal cortex ( p ≤ 0.001), compared to controls.
Nonmedicated patients showed a marginally significant increase in COX‐2 expression ( p = 0.047) and a significantly (−62%) reduced cPGES expression in frontal cortex ( p ≤ 0.001), compared to controls.
Medicated patients did not show any differences in the expression level of COX‐2 and cPGES compared to controls, except for a 27% decrease in cPGES in the frontal cortex of patients with BP that approached significance ( p = 0.054).
Subjects with dementia showed an almost twofold higher expression of the COX‐1 gene than nondemented subjects, but the difference did not reach statistical significance because of a high interindividual variability in the patient groups.